EMCURE (EMCURE) News
Follow EMCURE (EMCURE) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Emcure Pharmaceuticals Shares Jump 10% to Record High
The shares rose to Rs.2,180.80 on Wednesday after gaining 5% in the previous session, bringing the two-session rally to 16%.
EQUITY | Nov 04, 2026, 07:47 AM UTC
M
Emcure Pharma Shares Hit 10% Upper Circuit as Q2 Profit Rises
Emcure Pharmaceuticals reported an increase in consolidated net profit to ₹325.06 crore for the September quarter. Its shares rose 10% to the upper circuit on Wednesday.
EQUITY | Nov 04, 2026, 05:04 AM UTC
M
Emcure Pharma Reports Double-Digit Growth in September-Quarter Results
Emcure Pharma reported double-digit growth in revenue, EBITDA and net profit for the September quarter. Its shares gained as much as 7% in response to the results.
EQUITY | Nov 03, 2026, 09:11 AM UTC
M
CDSCO panel eases approval steps for generic lenacapavir
Indian drugmakers are moving closer to launching affordable generic lenacapavir after a CDSCO regulatory panel recommended waiving local late-stage clinical trials.
REGULATION | Sep 21, 2026, 09:21 AM UTC